Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greene, T.
Right arrow Articles by Yamamoto, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greene, T.
Right arrow Articles by Yamamoto, M. E.

Journal of the American Society of Nephrology, Vol 4, 1221-1236, Copyright © 1993 by American Society of Nephrology

REGULAR ARTICLES

Baseline characteristics in the Modification of Diet in Renal Disease Study [corrected and republished article originally printed in J Am Soc Nephrol 1993 May;3(11):1819-34]

T Greene, JJ Bourgoignie, V Habwe, JW Kusek, LG Snetselaar, JM Soucie and ME Yamamoto
Department of Biostatistics and Epidemiology, Cleveland Clinic Foundation, OH 44195-5196.

The Modification of Diet in Renal Disease Study is randomized, multicenter, clinical trial designed to determine the effects of three levels of dietary control of protein and phosphorus and two levels of blood pressure control on the rate of decline of kidney function among persons with chronic renal disease. Study participants were assigned to one of two studies, Study A or Study B, depending on their GFR just before randomization. Within each study, participants were randomly allocated to one of two levels of blood pressure control and to one of two dietary interventions according to separate 2 x 2 factorial designs. A total of 840 men and women aged 18 to 70 were randomized. This report summarizes the demographic, biochemical, and clinical characteristics of the randomized participants at the time of entry into the trail, overviews the protocol and purposes of the baseline period before randomization, and evaluates the balance among the treatment intervention groups within Studies A and B at the time of randomization. Major indicators of renal function were found to be well balanced among the treatment groups. Selected baseline characteristics of participants in the Modification of Diet in Renal Disease Study are compared with those of other renal clinical trials and with those of new cases of treated ESRD reported in the United States Renal Data System.


This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
V. Menon, M. G. Shlipak, X. Wang, J. Coresh, T. Greene, L. Stevens, J. W. Kusek, G. J. Beck, A. J. Collins, A. S. Levey, et al.
Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease
Ann Intern Med, July 3, 2007; 147(1): 19 - 27.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
V. Menon, L. Li, X. Wang, T. Greene, V. Balakrishnan, M. Madero, A. A. Pereira, G. J. Beck, J. W. Kusek, A. J. Collins, et al.
Adiponectin and Mortality in Patients with Chronic Kidney Disease
J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2599 - 2606.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
V. Menon, M. J. Sarnak, T. Greene, X. Wang, A. A. Pereira, G. J. Beck, J. W. Kusek, J. Selhub, A. J. Collins, A. S. Levey, et al.
Relationship Between Homocysteine and Mortality in Chronic Kidney Disease
Circulation, March 28, 2006; 113(12): 1572 - 1577.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
F. J. Gennari, V. L. Hood, T. Greene, X. Wang, and A. S. Levey
Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings
Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 52 - 57.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
V. Menon, T. Greene, A. A. Pereira, X. Wang, G. J. Beck, J. W. Kusek, A. J. Collins, A. S. Levey, and M. J. Sarnak
Glycosylated Hemoglobin and Mortality in Patients with Nondiabetic Chronic Kidney Disease
J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3411 - 3417.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
P. F. HALLORAN, A. MELK, and C. BARTH
Rethinking Chronic Allograft Nephropathy: The Concept of AcceleratedSenescence
J. Am. Soc. Nephrol., January 1, 1999; 10(1): 167 - 181.
[Full Text]

Home page
 HypertensionHome page
L. A. Hebert, J. W. Kusek, T. Greene, L. Y. Agodoa, C. A. Jones, A. S. Levey, J. A. Breyer, P. Faubert, H. A. Rolin, and S.-R. Wang
Effects of Blood Pressure Control on Progressive Renal Disease in Blacks and Whites
Hypertension, September 1, 1997; 30(3): 428 - 435.
[Abstract] [Full Text]

Home page
 NEJMHome page
J. Lemann, T. Shiigai, H. Nonoguchi, K. Tomita, S. Fishbane, S. Klahr, A. S. Levey, and G. J. Beck
Dietary Protein Restriction and Blood-Pressure Control in Chronic Renal Insufficiency
N. Engl. J. Med., August 11, 1994; 331(6): 405 - 406.
[Full Text]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673